risedronic acid has been researched along with Back Ache in 9 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " These results suggested that ECT in combination with risedronate was more effective than risedronate alone for reducing back pain in postmenopausal women with osteoporosis." | 2.77 | Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis. ( Iwamoto, J; Takakuwa, M, 2012) |
| "Back and knee pain is a widespread health problem and a serious threat to the quality of life (QOL) in middle-aged and older adults, as it frequently accompanies osteoporosis and osteoarthritis." | 2.76 | Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36. ( Fujii, Y; Fujita, T; Miyauchi, A; Nakajima, M; Ohue, M; Takagi, Y, 2011) |
| "Osteoporosis is a common condition in men that can have serious clinical consequences." | 2.74 | Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. ( Dorst, A; Faber, H; Farahmand, P; Ringe, JD, 2009) |
| "Osteoporosis is prevalent in men with an estimated one in eight men older than 50 years suffering from osteoporotic fracture, and a higher mortality rate after fracture among men compared with women." | 2.72 | Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. ( Dorst, A; Faber, H; Farahmand, P; Ringe, JD, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hongo, M | 1 |
| Miyakoshi, N | 1 |
| Kasukawa, Y | 1 |
| Ishikawa, Y | 1 |
| Shimada, Y | 1 |
| Ringe, JD | 2 |
| Farahmand, P | 2 |
| Faber, H | 2 |
| Dorst, A | 2 |
| Majima, T | 1 |
| Shimatsu, A | 1 |
| Komatsu, Y | 1 |
| Satoh, N | 1 |
| Fukao, A | 1 |
| Ninomiya, K | 1 |
| Matsumura, T | 1 |
| Nakao, K | 1 |
| Orita, S | 1 |
| Ohtori, S | 1 |
| Koshi, T | 1 |
| Yamashita, M | 1 |
| Yamauchi, K | 1 |
| Inoue, G | 1 |
| Suzuki, M | 1 |
| Eguchi, Y | 1 |
| Kamoda, H | 1 |
| Arai, G | 1 |
| Ishikawa, T | 1 |
| Miyagi, M | 1 |
| Ochiai, N | 1 |
| Kishida, S | 1 |
| Takaso, M | 1 |
| Aoki, Y | 1 |
| Toyone, T | 1 |
| Takahashi, K | 1 |
| Fujita, T | 1 |
| Ohue, M | 1 |
| Nakajima, M | 1 |
| Fujii, Y | 1 |
| Miyauchi, A | 1 |
| Takagi, Y | 1 |
| Hadji, P | 1 |
| Zanchetta, JR | 1 |
| Russo, L | 1 |
| Recknor, CP | 1 |
| Saag, KG | 1 |
| McKiernan, FE | 1 |
| Silverman, SL | 1 |
| Alam, J | 1 |
| Burge, RT | 1 |
| Krege, JH | 1 |
| Lakshmanan, MC | 1 |
| Masica, DN | 1 |
| Mitlak, BH | 1 |
| Stock, JL | 1 |
| Takakuwa, M | 1 |
| Iwamoto, J | 1 |
| Kishimoto, H | 1 |
1 review available for risedronic acid and Back Ache
| Article | Year |
|---|---|
[Risedronate treatment for osteoporosis].
Topics: Back Pain; Bone Density; Bone Resorption; Clinical Trials as Topic; Etidronic Acid; Femoral Neck Fra | 2004 |
7 trials available for risedronic acid and Back Ache
| Article | Year |
|---|---|
Additive effect of elcatonin to risedronate for chronic back pain and quality of life in postmenopausal women with osteoporosis: a randomized controlled trial.
Topics: Aged; Back Pain; Bone Density; Bone Density Conservation Agents; Calcitonin; Chronic Pain; Drug Ther | 2015 |
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study.
Topics: Aged; Back Pain; Bone Density Conservation Agents; Calcium; Drug Therapy, Combination; Etidronic Aci | 2009 |
Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study.
Topics: Aged; Asian People; Back Pain; Body Height; Bone Density; Bone Density Conservation Agents; Bone Rem | 2009 |
Comparison of the effects of elcatonin and risedronate on back and knee pain by electroalgometry using fall of skin impedance and quality of life assessment using SF-36.
Topics: Aged; Back Pain; Bone Density Conservation Agents; Calcitonin; Etidronic Acid; Female; Humans; Knee | 2011 |
The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures.
Topics: Aged; Back Pain; Bone Density; Bone Density Conservation Agents; Double-Blind Method; Etidronic Acid | 2012 |
Elcatonin in combination with risedronate is more effective than risedronate alone for relieving back pain in postmenopausal women with osteoporosis.
Topics: Aged; Aged, 80 and over; Analgesics; Back Pain; Bone Density; Bone Density Conservation Agents; Calc | 2012 |
Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
Topics: Aged; Back Pain; Bone Density; Bone Density Conservation Agents; Calcium; Etidronic Acid; Fractures, | 2006 |
1 other study available for risedronic acid and Back Ache
| Article | Year |
|---|---|
The effects of risedronate and exercise on osteoporotic lumbar rat vertebrae and their sensory innervation.
Topics: Afferent Pathways; Animals; Back Pain; Bone Density Conservation Agents; Cells, Cultured; Disease Mo | 2010 |